Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.00
Delayed Data
As of Apr 17
 -0.01 / -0.50%
Today’s Change
1.53
Today|||52-Week Range
4.30
+8.70%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a 0.00% increase from the last price of 2.00.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Protalix Biotherapeutics Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.02
Sales
$3.7M
Reporting Date
Jun 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 77.78%
 
 
 
 
 
 
Growthannually 65.63%
 
 
 
 
 
 

Sales

Growthquarterly 37.91%
 
 
 
 
 
 
Growthannually 248.75%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account